Printer Friendly

INCSTAR TO DISTRIBUTE MEDGENIX CYTOKINE IMMUNOASSAYS

 STILLWATER, Minn., July 14 /PRNewswire/ -- INCSTAR Corporation (AMEX: ISR) today reported that it has entered into an agreement with the Cyberfluor Division of Nordion International, Inc., a Canadian company, to exclusively distribute, in the United States and Canada, a line of immunoassay products for the measurement of cytokines. These products are manufactured by Nordion's Belgian subsidiary, Medgenix Diagnostics S.A., a leading supplier of cytokines in the European marketplace.
 Cytokines are a particular group of hormones which are involved in the control of the immune system and the body's response to viral and other infectious diseases, cancers, toxic-shock, auto-immune and rheumatic diseases. Cytokine measurement can provide researchers with important information about a patient's immune status.
 INCSTAR said that the cytokine products will be sold through its direct sales force in both the U.S. and Canada, and that it expects to begin shipments in the next few weeks.
 INCSTAR is a Minnesota-based manufacturer and distributor of high quality immunodiagnostic products for health care professionals and manufacturers. The company is an affiliate of the Italian-based Fiat Group (NYSE: FIA).
 -0- 7/14/93
 /CONTACT: Jack Falker of Swenson Falker Eilertsen, 612-371-0000, for INCSTAR; or John Booth of INCSTAR Corporation, 612-779-1700/
 (ISR FIA)


CO: INCSTAR Corporation ST: Minnesota IN: MTC SU: JVN

KH -- MN009 -- 1264 07/14/93 09:45 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 14, 1993
Words:219
Previous Article:WASHINGTON SCIENTIFIC ANNOUNCES SALE OF ADVANCED CUSTOM MOLDERS SUBSIDIARY; REPORTS THIRD QUARTER LOSS
Next Article:UNITED WISCONSIN SERVICES ANNOUNCES COMPLETION OF DEBT OFFERING
Topics:


Related Articles
INCSTAR NAMES VICE PRESIDENT OF RESEARCH AND DEVELOPMENT AND VICE PRESIDENT OF NEW TECHNOLOGY DEVELOPMENT
INCSTAR REPORTS NET LOSS FOR FIRST QUARTER OF 1993, NET OF WORKFORCE REDUCTION CHARGES
INCSTAR REPORTS SECOND QUARTER NET EARNINGS
INCSTAR REPORTS NET EARNINGS FOR 1993
T CELL SCIENCES TO MARKET TRAx(TM) CD4/CD8 WITH INCSTAR CORPORATION
INCSTAR REPORTS INCREASED FIRST QUARTER EARNINGS
INCSTAR DISCONTINUES R&D ON FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA) SYSTEM; PURSUES ALTERNATE NEW PRODUCT OPPORTUNITIES
ENDOGEN, INC. ACQUIRES TWO PRODUCT LINES FROM CYTOKINE SCIENCES, INC.
INCSTAR Corporation Announces Definitive Agreement Regarding Cash Merger
INCSTAR Corporation Announces Results of Its Special Meeting of Shareholders

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters